BioCorRx Inc. (OTCMKTS:BICX) Sees Large Growth in Short Interest

BioCorRx Inc. (OTCMKTS:BICX) saw a large increase in short interest during the month of March. As of March 15th, there was short interest totalling 7,100 shares, an increase of 222.7% from the February 28th total of 2,200 shares. Based on an average daily volume of 10,600 shares, the short-interest ratio is presently 0.7 days. Currently, 0.1% of the company’s shares are short sold.

BioCorRx Trading Down 0.3 %

Shares of OTCMKTS:BICX traded down $0.00 on Friday, reaching $0.35. 9,487 shares of the company traded hands, compared to its average volume of 13,987. The stock has a market capitalization of $5.58 million, a P/E ratio of -0.67 and a beta of 0.57. The business’s 50-day simple moving average is $0.39 and its 200 day simple moving average is $0.37. BioCorRx has a 52 week low of $0.26 and a 52 week high of $1.50.

BioCorRx Company Profile

BioCorRx Inc, through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition.